EUVIMEDEUVIMED entdecken
Crossref

Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer

Elisa Caron, Shreef Said, Hind Anan, Yashashwini Sudina, Dana Alameddine, Rabih Chaer, Marc Schermerhorn, Cassius Iyad Ochoa Chaar, Lars Stangenberg

Journal of Vascular Surgery · 2026-10

DOI: 10.1016/j.jvs.2026.09.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2026-10. Verfasst von Elisa Caron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Depar…. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Cancer is typically associated with venous thrombosis, but its impact on patients undergoing peripheral vascular interventions (PVIs) for concomitant peripheral arterial disease remains unclear. This multicenter study examines the characteristics of patients with active cancer and their outcomes after PVI. METHODS: Institutional Vascular Quality Initiative PVI data from three tertiary care centers (2019-2023) were combined and expanded through a retrospective chart review to include the presence and types of cancer. All adult patients undergoing endovascular intervention for peripheral arterial disease, including those with claudication, chronic limb-threatening ischemia, and acute limb ischemia, were included. The primary outcome was the composite of major amputation or mortality at 4 years in patients with cancer compared to those without. Additional long-term outcomes included reintervention, mortality, and major amputation at both 1 and 4 years. Secondary outcomes included perioperative outcomes. RESULTS: A total of 3072 patients were included. The incidence of active cancer was 2.2% (N = 68). Lung cancer was the most common, affecting 30.9% (N = 21) of patients. 53% (N = 36) presented with advanced stages (3/4) irrespective of cancer type. Patients with cancer were less likely to have diabetes. There was no significant difference in indication, but patients with cancer were more likely to get treated for aortoiliac disease and undergo stenting. Patients with cancer had a higher incidence of distal embolization (4.4% vs 0.6%; P = .012) and perioperative major amputation (4.4% vs 1.3%; P = .046). Kaplan-Meier analysis showed significantly higher mortality or amputation in patients with cancer up to 4 years (63% vs 35.1%; P < .001). Late outcomes in patients with cancer were driven by significantly higher mortality (52.2% vs 28.3%; P < .001) rather than adverse limb events (amputation: 14.7% vs 11.4%, P = .50; reintervention: 47.8% vs 48.3%, P = .80). Regression analysis demonstrated independent association of cancer with the composite outcome of mortality or major amputation (adjusted hazard ratio, 2.24; 95% confidence interval, 1.61-3.10). CONCLUSIONS: Active cancer affects a small proportion of patients undergoing PVI but has a significant impact on perioperative limb outcomes and long-term survival. This multicenter collaboration, combining registry data and electronic medical record review, can shed light on less common risk factors affecting lower-extremity revascularization.

Schlagwörter

Stichwörter der Autor:innen

Cancer-associated hypercoagulabilityCancer-associated thrombosisChronic limb-threatening ischemiaLimb salvagePeripheral arterial diseaseRevascularization outcomesperipheral vascular intervention

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Surgery, Boston Medical Center, Brighton, Boston University S…
  • Division of Vascular Surgery and Endovascular Therapy, Yale University School of Medicine, New Haven, CT.
  • Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: lstangen@bidmc.harvard.edu.

Zitieren

APA

Caron, E., Said, S., Anan, H., Sudina, Y., Alameddine, D., Chaer, R., Schermerhorn, M., Ochoa Chaar, C. I., & Stangenberg, L. (2026). Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2026.09.037

Vancouver

Caron E, Said S, Anan H, Sudina Y, Alameddine D, Chaer R, et al. Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2026.09.037

BibTeX
@article{Caron2026,
  author = {Caron, Elisa and Said, Shreef and Anan, Hind and Sudina, Yashashwini and Alameddine, Dana and Chaer, Rabih and Schermerhorn, Marc and Ochoa Chaar, Cassius Iyad and Stangenberg, Lars},
  title = {Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2026.09.037}
}
Kostenlos starten →